Accepted answer
To be exact about it, reverse-phase HPLC is the workhorse for peptide purity work, but it is almost universally run under conditions that are not optimal for a peptide of this chain length.
Trifluoroacetic acid at 0.1 per cent is the standard ion-pairing agent because it suppresses tailing by neutralising the basic residues, but it also suppresses mass spectrometry signal.
The underlying point is that mobile phase pH at the point where you inject must match the mobile phase pH at the start of the gradient, or the sample will not be focused at the column head.
The resolving power of a separation is quantified by the resolution parameter R, defined from the heights and widths of adjacent peaks, and pharmacopoeial methods typically demand R greater than 1.5 for a method to be considered validated.
Ask for the chromatogram and the system suitability data, not just the number.
edited 22 Mar 2026 by v_ramaswamy — added the placebo-arm figures
8Good answer, but the confidence interval in the cited trial is wider than implied. – fib4_reader 5 months ago add a comment